COVID-19 trials registries data warehouse

http://www.chictr.org.cn/showproj.aspx?proj=49902

Lianru Gao

lianru666@163.com

2020-02-22

Not recruiting

RCT

Randomized

Parallel

Not reported

multi-center

Treatment

1) age 18-80 years old, regardless of gender: 2) the diagnosis criteria of severe nCoV pneumonia in line with the 6th edition of China's new coronavirus pneumonia diagnosis scheme: a.B. Real-time fluorescence rt-pcr of respiratory tract specimens or blood samples was used to detect positive nCoV nucleic acid,3) critical cases of nCoV pneumonia: meet one of the following criteria: a. respiratory failure and mechanical ventilation required,B. shock,C. Combined with other organ failure, intensive care unit is required,4) patients with poor treatment response: that is, the above critically ill patients have undergone active modern medicine to fight against shock, correct acidosis, improve multi-organ function rescue and ECMO assisted breathing, and have not been improved by circulation assisted treatment and hormone application,5) those who signed the informed consent and agreed to participate in the initial clinical trial were selected.

No

2

The Sixth Medical Center of PLA General Hospital

18

80

China

Severe disease at enrollment

6: Severe disease at enrollment

40

The nucleic acid of the novel coronavirus is negative;CT scan of ground glass shadow disappeared;

| Declared number of arm (3.0) differs from found arms (4.0)

Phase 0

[{"arm_notes": "", "treatment_id": 787, "treatment_name": "Mesenchymal stem cells", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]